1,586
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Physicochemical characterization of atorvastatin calcium/ezetimibe amorphous nano-solid dispersions prepared by electrospraying method

, , , &
Pages 1138-1145 | Received 23 Apr 2016, Accepted 12 Jun 2016, Published online: 13 Jul 2016

References

  • Adibkia K, Barzegar-Jalali M, Maheri-Esfanjani H, Ghanbarzadeh S, Shokri J, Sabzevari A, Javadzadeh Y. 2013. Physicochemical characterization of naproxen solid dispersions prepared via spray drying technology. Powder Technol. 246:448–455.
  • Arunkumar N, Deecaraman M, Rani C, Mohanraj K, Venkates Kumar K. 2009. Preparation and solid state characterization of atorvastatin nanosuspensions for enhanced solubility and dissolution. Int J Pharm Tech Res. 1:1725–1730.
  • Bandyopadhyay S, Katare OP, Singh B. 2014. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv. 11:479–492.
  • Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, Mohammadi G, Hamidi A, Andalib S, Adibkia K. 2012. Comparison of physicochemical characteristics and drug release of diclofenac sodium–eudragit® RS100 nanoparticles and solid dispersions. Powder Technol. 219:211–216.
  • Barzegar-Jalali M, Valizadeh H, Shadbad M-RS, Adibkia K, Mohammadi G, Farahani A, Arash Z, Nokhodchi A. 2010. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol. 197:150–158.
  • Bays HE, Averna M, Majul C, Muller-Wieland D, De Pellegrin A, Giezek H, et al. 2013. Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemia. Am J Cardiol. 112:1885–1895.
  • Charifson PS, Walters WP. 2014. Acidic and basic drugs in medicinal chemistry: a perspective. J Med Chem. 57:9701–9717.
  • Constance C, Ben-Yehuda O, Wenger NK, Zieve F, Lin J, Hanson ME, Lowe RS, Tershakovec AM. 2014. Atorvastatin 10  mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years. Lipids Health Dis. 13:13.
  • Dixit RP, Barhate CR, Nagarsenker MS. 2008. Stability-indicating HPTLC method for simultaneous determination of ezetimibe and simvastatin. Chromatographia. 67:101–107.
  • Dixit RP, Nagarsenker MS. 2008. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci. 35:183–192.
  • Gulsun T, Gursoy RN, Oner L. 2011. Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull (Tokyo). 59:41–45.
  • Hamishehkar H, Shokri J, Fallahi S, Jahangiri A, Ghanbarzadeh S, Kouhsoltani M. 2015. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Drug Dev Ind Pharm. 41:1640–1646.
  • Jafari-Aghdam N, Adibkia K, Payab S, Barzegar-Jalali M, Parvizpur A, Mohammadi G, Sabzevari A. 2016. Methylprednisolone acetate–Eudragit® RS100 electrospuns: preparation and physicochemical characterization. Artif Cells Nanomed Biotechnol. 44:497–503.
  • Jahangiri A, Adibkia K, Asadpour-Zeynali K, Javadzadeh Y, Hamishehkar H, Barzegar-Jalali M. 2016. Application of multivariate calibration methods, in dissolution testing and simultaneous determination of atorvastatin and ezetimibe in their combined solid dosage form. Pharm Sci. 22:105–111.
  • Jahangiri A, Barzegar-Jalali M, Garjani A, Javadzadeh Y, Hamishehkar H, Afroozian A, Adibkia K. 2015a. Pharmacological and histological examination of atorvastatin-PVP K30 solid dispersions. Powder Technol. 286:538–545.
  • Jahangiri A, Barzegar-Jalali M, Garjani A, Javadzadeh Y, Hamishehkar H, Rameshrad M, Adibkia K. 2015b. Physicochemical characterization and pharmacological evaluation of ezetimibe-PVP K30 solid dispersions in hyperlipidemic rats. Colloids Surf B Biointerfaces. 134:423–430.
  • Jahangiri A, Davaran S, Fayyazi B, Tanhaei A, Payab S, Adibkia K. 2014. Application of electrospraying as a one-step method for the fabrication of triamcinolone acetonide-PLGA nanofibers and nanobeads. Colloids Surf B Biointerfaces. 123:219–224.
  • Kadu PJ, Kushare SS, Thacker DD, Gattani SG. 2011. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol. 16:65–74.
  • Kawakami K, Zhang S, Chauhan RS, Ishizuka N, Yamamoto M, Masaoka Y, et al. 2013. Preparation of fenofibrate solid dispersion using electrospray deposition and improvement in oral absorption by instantaneous post-heating of the formulation. Int J Pharm. 450:123–128.
  • Kim M-S, Jin S-J, Kim J-S, Park HJ, Song H-S, Neubert RH, Hwang S-J. 2008. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 69:454–465.
  • Leuner C, Dressman J. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 50:47–60.
  • Li Z, Wang C. 2013. Effects of Working Parameters on Electrospinning. One-Dimensional Nanostructures. New York (NY): Springer, pp. 15–28.
  • Liu Z-P, Cui L, Yu D-G, Zhao Z-X, Chen L. 2014. Electrosprayed core–shell solid dispersions of acyclovir fabricated using an epoxy-coated concentric spray head. Int J Nanomed. 9:1967.
  • Lopez FL, Shearman GC, Gaisford S, Williams GR. 2014. Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning. Mol Pharm. 11:4327–4338.
  • Lv HX, Zhang ZH, Hui J, Waddad AY, Zhou JP. 2012. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex. Pharmazie. 67:46–53.
  • Martos NR, Diaz AM, Navalon A, De Orbe Paya I, Capitan Vallvey LF. 2000. Simultaneous spectrofluorimetric determination of (acetyl)salicylic acid, codeine and pyridoxine in pharmaceutical preparations using partial least-squares multivariate calibration. J Pharm Biomed Anal. 23:837–844.
  • Meinel AJ, Germershaus O, Luhmann T, Merkle HP, Meinel L. 2012. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm. 81:1–13.
  • Mohammadi G, Hemati V, Nikbakht M-R, Mirzaee S, Fattahi A, Ghanbari K, Adibkia K. 2014. In vitro and in vivo evaluation of clarithromycin–urea solid dispersions prepared by solvent evaporation, electrospraying and freeze drying methods. Powder Technol. 257:168–174.
  • Mohammadian F, Eatemadi A. 2016. Drug loading and delivery using nanofibers scaffolds. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.1080/21691401.2016.1185726.
  • Morozov VN, Mikheev AY. 2012. Water-soluble polyvinylpyrrolidone nanofilters manufactured by electrospray-neutralization technique. J Membr Sci. 403:110–120.
  • Nagy ZK, Balogh A, Vajna B, Farkas A, Patyi G, Kramarics Á, Marosi G. 2012. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci. 101:322–332.
  • Paaver U, Heinämäki J, Laidmäe I, Lust A, Kozlova J, Sillaste E, et al. 2015. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs. Int J Pharm. 479:252–260.
  • Patel R, Bhimani D, Patel J, Patel D. 2008. Solid-state characterization and dissolution properties of ezetimibe–cyclodextrins inclusion complexes. J Inclus Phenom Macrocycl Chem. 60:241–251.
  • Payab S, Davaran S, Tanhaei A, Fayyazi B, Jahangiri A, Farzaneh A, Adibkia K. 2016. Triamcinolone acetonide-Eudragit RS100 nanofibers and nanobeads: morphological and physicochemical characterization. Artif Cells Nanomed Biotechnol. 44:362–369.
  • Quan J, Yu Y, Branford-White C, Williams GR, Yu D-G, Nie W, Zhu L-M. 2011. Preparation of ultrafine fast-dissolving feruloyl-oleyl-glycerol-loaded polyvinylpyrrolidone fiber mats via electrospinning. Colloids Surf B Biointerfaces. 88:304–309.
  • Sancheti PP, Karekar P, Vyas VM, Shah M, Pore YV. 2009. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie. 64:227–231.
  • Sethia S, Squillante E. 2004. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 272:1–10.
  • Singh B, Garg T, Goyal AK, Rath G. 2015. Development, optimization, and characterization of polymeric electrospun nanofiber: a new attempt in sublingual delivery of nicorandil for the management of angina pectoris. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1052472.
  • Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. 1999. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 181:143–151.
  • Taylor LS, Zografi G. 1997. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 14:1691–1698.
  • Thadkala K, Nanam PK, Rambabu B, Sailu C, Aukunuru J. 2014. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability. Int J Pharm Investig. 4:131–137.
  • Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P, Kinget R. 2001. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 12:261–269.
  • Verheyen S, Blaton N, Kinget R, Van den Mooter G. 2002. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm. 249:45–58.
  • Vo CL, Park C, Lee BJ. 2013. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 85:799–813.
  • Walton W. 1948. Feret’s statistical diameter as a measure of particle size. Nature. 162:329–330.
  • Wise BM, Gallagher NB. 1997. PLS-Toolbox 2.0 for Use with MATLAB. Manson (WA): Eigenvector Research; 17.
  • Yu D-G, Branford-White C, Shen X-X, Zhang X-F, Zhu L-M. 2010. Solid dispersions of ketoprofen in drug-loaded electrospun nanofibers. J Dispersion Sci Technol. 31:902–908.
  • Yu D-G, Branford-White C, White K, Li X-L, Zhu L-M. 2010. Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen. AAPS PharmSciTech. 11:809–817.
  • Yu D-G, Shen X-X, Branford-White C, White K, Zhu L-M, Bligh SA. 2009. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology. 20:055104.
  • Yu D-G, Yang J-M, Branford-White C, Lu P, Zhang L, Zhu L-M. 2010. Third generation solid dispersions of ferulic acid in electrospun composite nanofibers. Int J Pharm. 400:158–164.
  • Yu DG, Zhang XF, Shen XX, Brandford‐White C, Zhu LM. 2009. Ultrafine ibuprofen‐loaded polyvinylpyrrolidone fiber mats using electrospinning. Polym Int. 58:1010–1013.
  • Zamani M, Prabhakaran MP, Ramakrishna S. 2013. Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomed. 8:2997–3017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.